Valion Bio’s activist holder 3i, LP is associated with 3,334,139.00 shares, representing 9.9% of the common stock. The position includes direct common stock and securities convertible or exercisable into stock, while a 9.99% blocker applies to those transactions, giving investors the reported ownership structure.

Key Highlights

  • 3i, LP’s beneficial ownership includes 2,100,000 directly held common shares.
  • Another 1,234,139 shares may arise through warrants, a convertible note or Series B and Series C preferred stock.
  • The convertible note held by 3i, LP has an original principal amount of $16,253,147.10.

Valion Bio, Inc. (NASDAQ: VBIO) has a reported activist beneficial owner associated with 3,334,139 shares, equal to 9.9% of its common stock. 3i, LP is the direct reporting person, while 3i Management LLC and Maier J. Tarlow are also listed with 3,334,139 shares and 9.9%; Tumim Stone Capital, LLC is listed at 0.00%. The percentages are calculated against 32,140,634 common shares outstanding as of August 24, 2026.

Direct Shares And Conversion Rights

The reported position combines 2,100,000 common shares held directly by 3i, LP with 1,234,139 shares that may become issuable through several instruments. The potential issuance can result from exercises of warrants or conversions involving a senior secured convertible note, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock. The warrants, note and Preferred Shares are held directly by 3i, LP for the direct position. The same instruments are described as indirectly held for 3i Management LLC and Maier J. Tarlow.

9.99% Blocker Limits Transactions

The senior secured convertible note has an original principal amount of $16,253,147.10. The Series B and Series C preferred stock each carry a $0.0001 par value, as does Valion Bio’s common stock. The ownership update is dated 08/25/2026. Maier J. Tarlow signed for 3i Management LLC, Tumim Stone Capital, LLC and 3i, LP on 08/27/2026, and also signed individually.

Peers Moving on This News

  • LogicMark Inc (NASDAQ: LGMK) down 1.6%
  • Catheter Precision, Inc. (AMEX: VTAK) down 2.1%